Entries in Motrin (2)


Batches of Motrin Products Recalled Over Dissolving Issue

Charles D Winters/Photo Researchers/Getty Images(FORT WASHINGTON, Pa.) -- McNeil Consumer Healthcare Division announced Wednesday it is recalling batches of three of its Motrin products, citing problems with how the drugs dissolve.

The voluntary recall affects certain lots of Motrin IB 24-count coated caplets, Motrin IB 24-count coated tablets and Motrin IB 24+6 count coated caplets.  After testing product samples, the drugmaker found that "some caplets may not dissolve as quickly as intended when nearing their expiration date."

[Click here to see the full list of affected Motrin products]

McNeil notes that the affected products do not pose a safety concern for consumers -- those who continue taking the drugs may just experience a delay in relief.

The drugmaker says it is recalling the products "out of an abundance of caution," and that "consumers do not need to dispose of or return the product."

Copyright 2011 ABC News Radio


Motrin Lawsuit: Jury Awards Girl $10 Million for Burns and Blindness

Comstock/Thinkstock(NASHVILLE, Tenn.) -- When 3-year-old Brianna Maya began to cough and run a temperature on a Saturday night in November 2000, her parents followed their pediatrician's advice for any fever higher than 101.5, and gave her alternating doses of Children's Motrin and Children's Tylenol every three hours.

Over the next few days, a fine rash on her body and mild redness around her eyes morphed into something insidious: a rare, painful and potentially fatal skin reaction that burned and blistered her body inside and out, blinded her in one eye and left her fighting for her life in a burn unit 1,000 miles from home.

"It was like something you see in a science fiction movie," said her mother, Alicia E. Maya Donaldson, 34, an assistant professor of social work at the University of Tennessee at Martin, as she recalled how her daughter looked at the time.

Doctors at Shriners Burn Hospital in Galveston, Texas, concluded that Brianna's reaction was triggered by Children's Motrin, a brand of the popular anti-inflammatory drug ibuprofen.

On May 24, a jury in Philadelphia ordered the drug manufacturer, Johnson & Johnson's McNeil Consumer Healthcare, to pay Brianna's family $10 million for her injuries and for failing to adequately warn consumers about the toxic skin reaction she suffered.

In 2000, the label that her mother read on the Children's Motrin package made no mention of Brianna's diagnoses, Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome (Tens). Stevens-Johnson blisters and breaks down the mucus membranes of the cornea, mouth, rectum, vagina and urethra. Tens, a more severe form, affects a greater percentage of the skin and mucus membranes.

Stevens-Johnson and Tens are variously estimated to affect from one in a million to eight in a million people.

Brianna, now 13, has spent the last decade living the painful aftermath of SJS/Tens: She has undergone repeated eye surgeries and suffered recurrent eye and lung infections. Last summer, she developed seizures stemming from oxygen-deprivation during the worst of her illness. One of the ironies is that doctors have had difficulty controlling her seizures because anti-seizure drugs can trigger Stevens-Johnson syndrome. Because of vaginal scarring, "she will never be able to have normal sexual relations or bear children," her mother said.

"While we are sympathetic to the pain and hardships suffered by Brianna Maya and her family, McNeil-PPC Inc. strongly disagrees with the verdict, and we are considering legal options," said Marc Boston, a company spokesman. Children's Motrin is "safe and effective...when used as directed," he said.

Copyright 2011 ABC News Radio

ABC News Radio